Trial Profile
Phase Ib Clinical Trial of Roflumilast Added to Standard Chemoimmunotherapy for High-risk Diffuse Large B-cell Lymphoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Feb 2024
Price :
$35
*
At a glance
- Drugs Roflumilast (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 19 Feb 2024 Status changed from active, no longer recruiting to completed.
- 09 Feb 2023 Planned End Date changed from 1 Dec 2022 to 1 Dec 2025.
- 25 Jun 2021 Planned End Date changed from 1 Nov 2021 to 1 Dec 2022.